机译:Tenofovir Disoproxil对慢性乙型肝炎病毒感染治疗的十年疗效和安全性
Viral Hepatitis Research UnitH?pital BeaujonClichy France;
Toronto Centre for Liver DiseaseUniversity Health Network University of TorontoToronto Ontario;
Gastroenterology and Hepatology UnitMonash Health and Monash UniversityMelbourne Australia;
Liver Unit IFI‐Institute for Interdisciplinary MedicineAsklepios Klinik St GeorgHamburg Germany;
Liver Unit IFI‐Institute for Interdisciplinary MedicineAsklepios Klinik St GeorgHamburg Germany;
Department of Infectious Diseases and HepatologyMedical University BialystokBialystok Poland;
Department of Gastroenterology Hepatology and EndocrinologyHannover Medical SchoolHannover Germany;
Viral Hepatitis Investigative UnitUniversity of ManitobaWinnipeg Canada;
Clinic of GastroenterologySt Ivan Rilsky University Hospital Medical UniversitySofia Bulgaria;
Liver UnitUniversity of CalgaryCalgary Alberta Canada;
Gilead Sciences IncFoster City California;
Gilead Sciences IncFoster City California;
Gilead Sciences Europe LtdUxbridge UK;
Gilead Sciences IncFoster City California;
Gilead Sciences IncFoster City California;
Gilead Sciences IncFoster City California;
Liver UnitHospital Universitario Vall d’Hebron and CIBEREHD del Instituto Carlos IIIBarcelona Spain;
机译:Tenofovir Disoproxil对慢性乙型肝炎病毒感染治疗的十年疗效和安全性
机译:Besfovir Dipivoxil Mateate的疗效和安全性与诺福韦解毒富马酸盐治疗慢性乙型肝炎病毒感染相比
机译:替诺福韦富马酸替诺福韦酯治疗慢性乙型肝炎的三年疗效和安全性。
机译:替诺福韦富马酸替诺福韦抗乙肝病毒感染治疗动力学建模与仿真
机译:用于治疗慢性乙型肝炎病毒感染的病毒疫苗载体。
机译:替诺福韦富马酸替诺福韦酯治疗慢性乙型肝炎病毒的七年疗效和安全性
机译:替诺福韦富马酸替诺福韦酯治疗慢性乙型肝炎病毒的七年疗效和安全性